PharmGKB pharmacogenomics annotation skill for drug-gene interaction assessment
Scanned 9/2/2026
Install to Claude Code
npx -y skills add a5c-ai/babysitter --skill pharmgkb-annotator --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Pharmgkb Annotator?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/a5c-ai-pharmgkb-annotator-babysitter)More formats (shields.io, HTML) on the badges page.
---
name: pharmgkb-annotator
description: PharmGKB pharmacogenomics annotation skill for drug-gene interaction assessment
allowed-tools:
- Read
- Write
- Glob
- Grep
- Edit
- WebFetch
- WebSearch
- Bash
metadata:
version: "1.0"
category: bioinformatics
tags:
- clinical-genomics
- pharmacogenomics
- drug-response
- cpic
graph:
domains: [domain:bioinformatics]
specializations: [specialization:biomedical-informatics]
skillAreas: [skill-area:data-analysis, skill-area:statistical-analysis, skill-area:python-data-pipelines]
workflows: [workflow:experiment-design]
roles: [role:biomedical-engineer, role:research-scientist]
---
# PharmGKB Annotator Skill
## Purpose
Provide PharmGKB pharmacogenomics annotation for drug-gene interaction assessment.
## Capabilities
- Star allele calling (Stargazer)
- Diplotype determination
- CPIC guideline integration
- Drug recommendation generation
- Clinical annotation lookup
- Dosing guidance extraction
## Usage Guidelines
- Call star alleles accurately
- Determine diplotypes from genotypes
- Apply CPIC guidelines for dosing
- Generate actionable recommendations
- Review clinical annotations
- Document guideline versions
## Dependencies
- PharmGKB API
- Stargazer
- PharmCAT
## Process Integration
- Pharmacogenomics Analysis (pharmacogenomics-analysis)
- Clinical Variant Interpretation (clinical-variant-interpretation)
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!